{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T13:09:26Z","timestamp":1763644166370,"version":"3.41.2"},"reference-count":54,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780443223143"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/bs.pmbts.2023.12.013","type":"book-chapter","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T08:14:11Z","timestamp":1706170451000},"page":"287-300","source":"Crossref","is-referenced-by-count":4,"title":["RNA therapeutics for treatment of diabetes"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.pmbts.2023.12.013_bib1","article-title":"Dietary factors associated with glycemic control in children and adolescents with type 1 diabetes","author":"Zakarneh","year":"2023","journal-title":"Curr Pediatr Rev"},{"issue":"4","key":"10.1016\/bs.pmbts.2023.12.013_bib2","doi-asserted-by":"crossref","first-page":"994","DOI":"10.2337\/dc21-1752","article-title":"The incidence of adult-onset type 1 diabetes: a systematic review from 32 countries and regions","volume":"45","author":"Harding","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/bs.pmbts.2023.12.013_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.885650","article-title":"Circular RNAs in diabetes mellitus and its complications","volume":"13","author":"Fan","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/bs.pmbts.2023.12.013_bib4","first-page":"179","article-title":"Type 2 diabetes mellitus and nonvalvular atrial fibrillation in Mexico: national registries raise a red flag","volume":"75","author":"Marquez-Murillo","year":"2023","journal-title":"Rev Invest Clin"},{"issue":"7","key":"10.1016\/bs.pmbts.2023.12.013_bib5","article-title":"Psychosocial development in saudi adolescents with type 1 diabetes mellitus: a descriptive comparative study","volume":"15","author":"Hamzah","year":"2023","journal-title":"Cureus"},{"issue":"Spec No4","key":"10.1016\/bs.pmbts.2023.12.013_bib6","first-page":"109","article-title":"Diet recomendations in diabetes and obesity","volume":"35","author":"Riobo Servan","year":"2018","journal-title":"Nutr Hosp"},{"issue":"5","key":"10.1016\/bs.pmbts.2023.12.013_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/nu11050962","article-title":"Low-carb and ketogenic diets in type 1 and type 2 diabetes","volume":"11","author":"Bolla","year":"2019","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.12.013_bib8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/dom.13088","article-title":"Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: a systematic review","volume":"20","author":"Khunti","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.12.013_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2016.7","article-title":"Recent progress in genetic and epigenetic research on type 2 diabetes","volume":"48","author":"Kwak","year":"2016","journal-title":"Exp Mol Med"},{"issue":"8","key":"10.1016\/bs.pmbts.2023.12.013_bib10","doi-asserted-by":"crossref","DOI":"10.1007\/s11892-019-1173-y","article-title":"The genetic epidemiology of type 2 diabetes: opportunities for health translation","volume":"19","author":"Meigs","year":"2019","journal-title":"Curr Diab Rep"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.12.013_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/nyas.12757","article-title":"Personalized medicine in diabetes mellitus: current opportunities and future prospects","volume":"1346","author":"Kleinberger","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/bs.pmbts.2023.12.013_bib12","doi-asserted-by":"crossref","first-page":"3937893","DOI":"10.1155\/2017\/3937893","article-title":"Genetic epidemiology of type 2 diabetes in mexican mestizos","volume":"2017","author":"Garcia-Chapa","year":"2017","journal-title":"Biomed Res Int"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.12.013_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00384-023-04509-3","article-title":"The impact of the incidence of diabetic complications on mortality in colorectal cancer patients with diabetes: a nationwide study","volume":"38","author":"Lee","year":"2023","journal-title":"Int J Colorectal Dis"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.12.013_bib14","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.3390\/nursrep13030093","article-title":"Knowledge of diabetic retinopathy among primary care nurses performing fundus photography and agreement with ophthalmologists on screening","volume":"13","author":"Fernandez-Gutierrez","year":"2023","journal-title":"Nurs Rep"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.12.013_bib15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3390\/pathophysiology30030026","article-title":"Pathophysiology of red blood cell dysfunction in diabetes and its complications","volume":"30","author":"Williams","year":"2023","journal-title":"Pathophysiology"},{"issue":"7","key":"10.1016\/bs.pmbts.2023.12.013_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2023.119530","article-title":"Inhibiting autophagy by miR-19a-3p\/PTEN regulation protected retinal pigment epithelial cells from hyperglycemic damage","volume":"1870","author":"Gong","year":"2023","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.12.013_bib17","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s42003-023-05064-x","article-title":"Circular RNA RSU1 promotes retinal vascular dysfunction by regulating miR-345-3p\/TAZ","volume":"6","author":"Zhang","year":"2023","journal-title":"Commun Biol"},{"issue":"7","key":"10.1016\/bs.pmbts.2023.12.013_bib18","doi-asserted-by":"crossref","first-page":"958","DOI":"10.4239\/wjd.v14.i7.958","article-title":"Novel insights regarding the role of noncoding RNAs in diabetes","volume":"14","author":"Macvanin","year":"2023","journal-title":"World J Diabetes"},{"key":"10.1016\/bs.pmbts.2023.12.013_bib19","unstructured":"Kovacs B, et al. MicroRNAs in Early Diabetic Retinopathy in Streptozotocin-Induced Diabetic Rats. (1552\u20135783 (Electronic))."},{"key":"10.1016\/bs.pmbts.2023.12.013_bib20","unstructured":"Daugaard I, Hansen TB. Biogenesis and Function of Ago-Associated RNAs. (0168\u20139525 (Print))."},{"issue":"2","key":"10.1016\/bs.pmbts.2023.12.013_bib21","first-page":"187","article-title":"Therapeutic siRNA: principles, challenges, and strategies","volume":"85","author":"Gavrilov","year":"2012","journal-title":"Yale J Biol Med"},{"key":"10.1016\/bs.pmbts.2023.12.013_bib23","unstructured":"Lei L, et al. Functions and Regulatory Mechanisms of Metastasis-Associated Lung Adenocarcinoma Transcript 1. (1097\u20134652 (Electronic))."},{"key":"10.1016\/bs.pmbts.2023.12.013_bib24","unstructured":"Abdulle LE, et al. MALAT1 as a Diagnostic and Therapeutic Target in Diabetes-Related Complications: A Promising Long-Noncoding RNA. (1449\u20131907 (Electronic))."},{"issue":"1","key":"10.1016\/bs.pmbts.2023.12.013_bib25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12872-018-0939-5","article-title":"Current status and strategies of long noncoding RNA research for diabetic cardiomyopathy","volume":"18","author":"Pant","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.12.013_bib26","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s42003-022-03728-8","article-title":"The whole-transcriptome landscape of diabetes-related sarcopenia reveals the specific function of novel lncRNA Gm20743","volume":"5","author":"Yu","year":"2022","journal-title":"Commun Biol"},{"issue":"4","key":"10.1016\/bs.pmbts.2023.12.013_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/1755-5922.12436","article-title":"Noncoding RNAs as therapeutic targets in atherosclerosis with diabetes mellitus","volume":"36","author":"Tang","year":"2018","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/bs.pmbts.2023.12.013_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110509","article-title":"Emerging roles of non-coding RNAs in the pathogenesis of type 1 diabetes mellitus","volume":"129","author":"Taheri","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"10.1016\/bs.pmbts.2023.12.013_bib29","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1159\/000494576","article-title":"LncRNA KCNQ1OT1 mediates pyroptosis in diabetic cardiomyopathy","volume":"50","author":"Yang","year":"2018","journal-title":"Cell Physiol Biochem"},{"issue":"7441","key":"10.1016\/bs.pmbts.2023.12.013_bib30","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature11993","article-title":"Natural RNA circles function as efficient microRNA sponges","volume":"495","author":"Hansen","year":"2013","journal-title":"Nature"},{"issue":"12","key":"10.1016\/bs.pmbts.2023.12.013_bib31","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.cell.2022.04.021","article-title":"Circular RNAs: characterization, cellular roles, and applications","volume":"185","author":"Liu","year":"2022","journal-title":"Cell"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.12.013_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030659","article-title":"circRNAs signature as potential diagnostic and prognostic biomarker for diabetes mellitus and related cardiovascular complications","volume":"9","author":"Zaiou","year":"2020","journal-title":"Cells"},{"key":"10.1016\/bs.pmbts.2023.12.013_bib33","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.metabol.2018.07.001","article-title":"MicroRNAs and type 2 diabetes mellitus: molecular mechanisms and the effect of antidiabetic drug treatment","volume":"87","author":"Yaribeygi","year":"2018","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.12.013_bib34","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1590\/2175-8239-jbn-2018-0165","article-title":"MicroRNAs: new biomarkers and promising therapeutic targets for diabetic kidney disease","volume":"41","author":"Nascimento","year":"2019","journal-title":"J Bras Nefrol"},{"issue":"44","key":"10.1016\/bs.pmbts.2023.12.013_bib35","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1093\/eurheartj\/eht032","article-title":"Platelets, endothelium, and circulating microRNA-126 as a prognostic biomarker in cardiovascular diseases: per aspirin ad astra","volume":"34","author":"Cavarretta","year":"2013","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/bs.pmbts.2023.12.013_bib36","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/ATVBAHA.119.310961","article-title":"Diabetes mellitus and cardiovascular disease","volume":"39","author":"Schmidt","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.12.013_bib37","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/ATVBAHA.108.179283","article-title":"Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses","volume":"30","author":"Yvan-Charvet","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"15","key":"10.1016\/bs.pmbts.2023.12.013_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241511977","article-title":"Decoding of miR-7-5p in colony forming unit-hill colonies as a biomarker of subclinical cardiovascular disease\u2014a MERIT study","volume":"24","author":"Bakhashab","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/bs.pmbts.2023.12.013_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166839","article-title":"The circRNA MKLN1 regulates autophagy in the development of diabetic retinopathy","volume":"1869","author":"Yang","year":"2023","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/bs.pmbts.2023.12.013_bib40","first-page":"1","article-title":"CircRNA-SCAF8 promotes vascular endothelial cell pyroptosis by regulating the circRNA-SCAF8\/miR-93-5p\/TXNIP axis","author":"Wang","year":"2023","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"issue":"14","key":"10.1016\/bs.pmbts.2023.12.013_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411606","article-title":"Targeted microRNA profiling reveals that exendin-4 modulates the expression of several microRNAs to reduce steatosis in HepG2 cells","volume":"24","author":"Khalifa","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/bs.pmbts.2023.12.013_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/genes13050747","article-title":"Genetic variants of MIR27A, MIR196A2 may impact the risk for the onset of coronary artery disease in the Pakistani population","volume":"13","author":"Haq","year":"2022","journal-title":"Genes (Basel)"},{"issue":"4","key":"10.1016\/bs.pmbts.2023.12.013_bib43","article-title":"Impacts of microRNA-483 on human diseases","volume":"9","author":"Matson","year":"2023","journal-title":"Noncoding RNA"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.12.013_bib44","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/1061186X.2018.1476518","article-title":"siRNA: an alternative treatment for diabetes and associated conditions","volume":"27","author":"Shende","year":"2019","journal-title":"J Drug Target"},{"key":"10.1016\/bs.pmbts.2023.12.013_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106135","article-title":"Exosomal ncRNAs: novel therapeutic target and biomarker for diabetic complications","volume":"178","author":"Xu","year":"2022","journal-title":"Pharmacol Res"},{"issue":"7","key":"10.1016\/bs.pmbts.2023.12.013_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/genes14071429","article-title":"Non-coding RNAs in human health and diseases","volume":"14","author":"Good","year":"2023","journal-title":"Genes (Basel)"},{"issue":"13","key":"10.1016\/bs.pmbts.2023.12.013_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310777","article-title":"Effects of miR-33 deficiency on metabolic and cardiovascular diseases: implications for therapeutic intervention","volume":"24","author":"Ortega","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.12.013_bib48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.59566\/IJBS.2017.13048","article-title":"Molecular mechanisms and biological functions of siRNA","volume":"13","author":"Dana","year":"2017","journal-title":"Int J Biomed Sci"},{"key":"10.1016\/bs.pmbts.2023.12.013_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155657","article-title":"SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis","volume":"146","author":"Shen","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/bs.pmbts.2023.12.013_bib50","doi-asserted-by":"crossref","first-page":"1217985","DOI":"10.3389\/fcvm.2023.1217985","article-title":"The role of lncRNA-mediated pyroptosis in cardiovascular diseases","volume":"10","author":"Hu","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/bs.pmbts.2023.12.013_bib51","doi-asserted-by":"crossref","first-page":"1179161","DOI":"10.3389\/fendo.2023.1179161","article-title":"Roles of microRNA-192 in diabetic nephropathy: the clinical applications and mechanisms of action","volume":"14","author":"Wan","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"10.1016\/bs.pmbts.2023.12.013_bib52","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/jdi.14039","article-title":"miR-31 ameliorates type 2 diabetic vascular damage through up-regulation of hypoxia-inducible factor-1alpha\/vascular endothelial growth factor-A","volume":"14","author":"Fu","year":"2023","journal-title":"J Diabetes Investig"},{"issue":"5","key":"10.1016\/bs.pmbts.2023.12.013_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/genes12050664","article-title":"Deciphering the variants located in the MIR196A2, MIR146A, and MIR423 with Type-2 Diabetes Mellitus in Pakistani Population","volume":"12","author":"Khan","year":"2021","journal-title":"Genes (Basel)"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.12.013_bib54","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10142-022-00947-4","article-title":"Non-coding RNAs in human health and disease: potential function as biomarkers and therapeutic targets","volume":"23","author":"Loganathan","year":"2023","journal-title":"Funct Integr Genomics"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.12.013_bib55","first-page":"313","article-title":"Association between rs11614913 polymorphism of the MiR-196-a2 gene and colorectal cancer in the presence of departure from Hardy-Weinberg equilibrium","volume":"23","author":"Soltanian","year":"2021","journal-title":"Cell J"}],"container-title":["Progress in Molecular Biology and Translational Science","RNA Therapeutics Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117323001953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117323001953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T15:07:48Z","timestamp":1754147268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117323001953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9780443223143"],"references-count":54,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2023.12.013","relation":{},"ISSN":["1877-1173"],"issn-type":[{"type":"print","value":"1877-1173"}],"subject":[],"published":{"date-parts":[[2024]]}}}